Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Rat E-Selectin/CD62E Fc Chimera Protein

Catalog No. 977ES100
Click to view available options
Quantity:
100 μg
This item is not returnable. View return policy
This item is not returnable. View return policy

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Rat E-Selectin/CD62E Fc Chimera Protein is derived from NS0. The Recombinant Rat E-Selectin/CD62E Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

Formulation Lyophilized from a 0.2μm filtered solution in Tris-Citrate.
Gene ID (Entrez) 25544
Molecular Weight (g/mol) 78 kDa (monomer)
Name E-Selectin/CD62E Fc Chimera
Quantity 100 μg
Source Mouse myeloma cell line,NS0-derived rat E-Selectin/CD62E protein, (N-terminus) Rat E-Selectin (Trp22-Pro494) Accession &Num; P98105 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Structural Form Disulfide-linked homodimer
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.